|
|
|
Insider
Information: |
Schall Thomas J. |
Relationship: |
|
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,900 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,900 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chemocentryx, Inc. |
CCXI |
President and CEO, Dir... |
2022-10-20 |
0 |
|
0 |
Premium* |
|
Immuneering Corp |
IMRX |
|
2024-03-22 |
2,900 |
2024-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-05-12 |
4 |
OE |
$14.31 |
$513,228 |
D/D |
35,865 |
2,304,422 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-06-12 |
4 |
OE |
$14.31 |
$1,270,055 |
D/D |
88,753 |
2,357,310 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-06-12 |
4 |
AS |
$65.08 |
$5,775,877 |
D/D |
(88,753) |
2,268,557 |
0 |
% |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-06-15 |
4 |
OE |
$14.31 |
$28,620 |
D/D |
2,000 |
2,270,557 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-06-15 |
4 |
AS |
$65.04 |
$130,090 |
D/D |
(2,000) |
2,268,557 |
0 |
% |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-12-14 |
4 |
OE |
$14.31 |
$159,599 |
D/D |
11,153 |
2,279,710 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-12-14 |
4 |
AS |
$65.03 |
$725,246 |
D/D |
(11,153) |
2,268,557 |
0 |
% |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-12-15 |
4 |
AS |
$65.01 |
$1,145,450 |
D/D |
(17,619) |
2,268,557 |
0 |
% |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2020-12-15 |
4 |
OE |
$14.31 |
$252,128 |
D/D |
17,619 |
2,286,176 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,899 |
2,356,456 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2021-01-01 |
4 |
D |
$61.92 |
$2,945,906 |
D/D |
(47,576) |
2,308,880 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2021-12-01 |
4 |
OE |
$10.27 |
$499,994 |
D/D |
45,936 |
2,354,816 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
84,234 |
2,439,050 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2022-01-01 |
4 |
D |
$36.41 |
$1,663,864 |
D/D |
(45,698) |
2,393,352 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2022-08-04 |
4 |
OE |
$14.28 |
$1,856,400 |
D/D |
130,000 |
2,523,352 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2022-08-04 |
4 |
AS |
$50.24 |
$6,531,733 |
D/D |
(130,000) |
2,393,352 |
0 |
% |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2022-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,393,352) |
0 |
0 |
- |
|
IMRX |
Immuneering Corp |
|
|
2024-03-22 |
4 |
B |
$2.55 |
$7,385 |
D/D |
2,900 |
2,900 |
0.01 |
- |
|
CCXI |
Chemocentryx, Inc. |
President and CEO |
|
2015-12-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
2,139,667 |
0 |
- |
|
144 Records found
|
|
Page 6 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|